Reuters
Biggest U.S. banks says they submitted $45.8 billion in loans for emergency aid program
The two largest U.S. banks, JPMorgan Chase & Co and Bank of America, said on Thursday that they submitted almost half a million applications worth nearly $46 billion to the Small Business Administration's Paycheck Protection Program for small businesses hurt by the coronavirus shutdown.
Categories: Reuters
Tesla cuts price for China-made Model 3 cars by 10% to qualify for subsidies
U.S. electric vehicle maker Tesla Inc said in Friday it has cut the starting price for China-made Model 3 sedans by 10% to qualify for subsidies in the world's biggest auto market.
Categories: Reuters
Amazon sees possible second-quarter loss as it forecasts $4 billion in COVID-19-related costs
Amazon.com Inc on Thursday said it could post its first quarterly loss in five years even as revenue surges because it is spending at least $4 billion in response to the coronavirus pandemic, including plans to test its workforce for COVID-19.
Categories: Reuters
Boeing raises $25 billion in blowout debt sale
Boeing Co raised $25 billion in a bond offering on Thursday, a blowout result for the planemaker, which is shoring up its finances during the coronavirus-induced travel downturn.
Categories: Reuters
Boeing says will not seek further funds from U.S. govt
Boeing Co has no plans to seek additional funding through the capital markets or from the U.S. government at this time, the planemaker said in a statement on Thursday.
Categories: Reuters
Trump threatens new tariffs on China as U.S. mulls retaliatory action over virus
U.S. President Donald Trump said on Thursday his hard-fought trade deal with China was now of secondary importance to the coronavirus pandemic and he threatened new tariffs on Beijing, as his administration crafted retaliatory measures over the outbreak.
Categories: Reuters
Gilead to work with partners to ramp up production of potential coronavirus treatment
Gilead Sciences Inc , maker of the closely-watched experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
Categories: Reuters
American Airlines, Delta, United to require facial coverings on U.S. flights
Three of the largest four U.S. airlines said Thursday they will require passengers to wear facial coverings on U.S. flights, joining JetBlue Airways Corp in taking the step to address the spread of the coronavirus and convince reluctant passengers to resume flying.
Categories: Reuters
Apple sales inch higher despite coronavirus but CEO Tim Cook sees uncertain future
Apple Inc reported sales and profits that beat Wall Street expectations Thursday, with Chief Executive Officer Tim Cook saying China sales were "headed in the right direction" as that country reopens from the novel coronavirus.
Categories: Reuters
Wall St. caps best month in decades with broad sell-off
U.S. stocks lost ground on Thursday as grim economic data and mixed earnings prompted investors to take profits at the close of the S&P 500's best month in 33 years, a remarkable run driven by expectations the economy will soon start recovering from crushing restrictions enacted to curb the coronavirus pandemic.
Categories: Reuters
Amgen studying Otezla for coronavirus, looking into other treatments
Amgen Inc on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.
Categories: Reuters
Amgen studying Otezla for coronavirus, first-quarter results beat Street estimates
Amgen Inc on Thursday reported better-than-expected first-quarter results and said it plans to study psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the new coronavirus.
Categories: Reuters
Boeing set to raise $25 billion in massive debt sale: sources
Boeing Co expects to raise around $25 billion in its bond offering on Thursday, according to people familiar with the matter, a blowout result for the planemaker shoring up its finances during the coronavirus-induced travel downturn.
Categories: Reuters
Amazon sees $4 billion in COVID-19-related costs, may not make second-quarter profit
Amazon.com Inc on Thursday said it could post its first quarterly loss in five years because it is spending at least $4 billion in response to the coronavirus pandemic, including plans to test its workers for COVID-19 and providing them with protective gear, and paying higher wages.
Categories: Reuters
United Airlines posts quarterly loss, shores up $9.6 billion in liquidity
United Airlines Holdings Inc on Thursday posted a first-quarter loss of $1.7 billion, including charges against investments in Latin America that have soured as the coronavirus pandemic jolts travel industries worldwide.
Categories: Reuters
Gilead aims to expand remdesivir output for COVID-19, posts flat 1st-quarter results
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday said it will work with international partners to expand production of the potential COVID-19 treatment.
Categories: Reuters
ConocoPhillips to sharply cut oil production as low prices hit earnings
ConocoPhillips said on Thursday it would sharply reduce oil output in coming weeks, aiming to shut 35% of its volume by June after weak energy prices led to a loss of $1.7 billion in the first quarter.
Categories: Reuters
Amazon's second-quarter forecast weighed down by $4 billion in COVID-19 related costs, shares fall
Amazon.com Inc on Thursday warned that it could post a loss in the second quarter as it tacked on about $4 billion in costs related to the COVID-19 pandemic, sending its shares down 5% in extended trade.
Categories: Reuters
Apple reports higher sales as China reopens after coronavirus but gives no forecast
Apple Inc reported sales and profits that beat Wall Street expectations Thursday, with Chief Executive Officer Tim Cook saying China sales were "headed in the right direction" as that country reopens from the novel coronavirus.
Categories: Reuters
Gilead aims to expand remdesivir output for COVID-19, posts flat first-quarter results
Gilead Sciences Inc , maker of the experimental coronavirus drug remdesivir, on Thursday reported flat first-quarter earnings and said it with work with international partners to expand production of potential COVID-19 treatment.
Categories: Reuters